DA
NEOS

DSC Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

DSC Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-330,576
Closed -$2.74M – 99
2018
Q1 		$2.74M Sell
330,576
-330,469
-50% -$3.16M 0.57% 25
2017
Q4 		$6.74M Sell
661,045
-382,725
-37% -$3.67M 3.91% 8
2017
Q3 		$9.55M Hold
1,043,770
– – 3.04% 6
2017
Q2 		$7.62M Hold
1,043,770
– – 2.51% 8
2017
Q1 		$7.51M Buy
1,043,770
+350,188
+50% +$2.17M 5.12% 8
2016
Q4 		$4.06M Sell
693,582
-91,122
-12% -$617K 2.3% 17
2016
Q3 		$5.16M Buy
784,704
+91,122
+13% +$722K 3.14% 12
2016
Q2 		$6.44M Hold
693,582
– – 4.05% 8
2016
Q1 		$7.48M Sell
693,582
-245,016
-26% -$2.58M 4.45% 8
2015
Q4 		$13.1M Buy
938,598
+31,240
+3% +$471K 6.84% 4
2015
Q3 		$17.2M Buy
+907,358
New +$20M 8.33% 2

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

DSC Advisors's NEOS Position: Q2 2018 in Review

DSC Advisors sold out of Neos Therapeutics, Inc (NEOS) in Q2 2018, closing a stake of 330,576 shares — an estimated $2.74M sold.

DSC Advisors first reported a position in NEOS in Q3 2015 and held it in 11 quarters. The position peaked at $17.2M in Q3 2015. 73 funds tracked by Wall St. Rank hold NEOS as of Q2 2018.

  • DSC Advisors reported no remaining Neos Therapeutics, Inc position as of Q2 2018 after selling out during the quarter.
  • DSC Advisors sold 330,576 Neos Therapeutics, Inc shares in Q2 2018, an estimated $2.74M.
  • DSC Advisors first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 11 quarters.
  • DSC Advisors's Neos Therapeutics, Inc position peaked at $17.2M in Q3 2015.
  • 73 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2018.

Based on DSC Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.